CNS Lymphoma
Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
PentixaPharmGermany - Würzburg
2 programs1
1
68Ga-PTFPhase 21 trial
[90Y]Y-PentixaTherPhase 1/21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
PentixaPharm68Ga-PTF
PentixaPharm[90Y]Y-PentixaTher
Gossamer BioGB5121
Clinical Trials (3)
Total enrollment: 12 patients across 3 trials
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
Start: Oct 2022Est. completion: Jan 2023
Phase 2Terminated
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
Start: Nov 2023Est. completion: Mar 2028
Phase 1/2Recruiting
GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma
Start: May 2022Est. completion: May 202312 patients
Phase 1Terminated
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 12 patients
2 companies competing in this space